Anavex Life Sciences Corp. (AVXL) stock
AVXLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 28, 2026Score 6/30
$0.67−0.05 (-7.21%)
Close on Nov 19, 2026Market cap $61.88MP/E –Yield –
Anavex Life Sciences total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
For fiscal 2015 it was $332, down 100.0% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2015 | Sep 30, 2015 | $332 | -100.0% |
| FY2014 | Sep 30, 2014 | $5.72M | – |
See a number that looks wrong?